Michael J. Newman Ph.D.
Net Worth
Last updated:
What is Michael J. Newman Ph.D. net worth?
The estimated net worth of Dr. Michael J. Newman Ph.D. is at least $10,798,509 as of 1 Feb 2022. He owns shares worth $10,098,467 as insider, has earned $100,042 from insider trading and has received compensation worth at least $600,000 in Indaptus Therapeutics, Inc..
What is the salary of Michael J. Newman Ph.D.?
Dr. Michael J. Newman Ph.D. salary is $200,000 per year as Founder, Chief Scientific Officer & Director in Indaptus Therapeutics, Inc..
How old is Michael J. Newman Ph.D.?
Dr. Michael J. Newman Ph.D. is 69 years old, born in 1956.
What stocks does Michael J. Newman Ph.D. currently own?
As insider, Dr. Michael J. Newman Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | Founder, Chief Scientific Officer & Director | 1,368,356 | $7.38 | $10,098,467 |
What does Indaptus Therapeutics, Inc. do?
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B virus and human immunodeficiency virus infection, which is in Phase I clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. was incorporated in 2021 and is headquartered in New York, New York.
Michael J. Newman Ph.D. insider trading
Indaptus Therapeutics, Inc.
Dr. Michael J. Newman Ph.D. has made 2 insider trades in 2022, according to the Form 4 filled with the SEC. Most recently he sold 14,130 units of INDP stock worth $70,692 on 1 Feb 2022.
The largest trade he's ever made was exercising 14,130 units of INDP stock on 1 Feb 2022. As of 1 Feb 2022 he still owns at least 1,368,356 units of INDP stock.
Indaptus Therapeutics key executives
Indaptus Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Michael J. Newman Ph.D. (69) Founder, Chief Scientific Officer & Director
- Mr. Jeffrey A. Meckler (58) Chief Executive Officer & Director
- Mr. Nir Sassi (49) Chief Financial Officer
- Mr. Walt Addison Linscott Esq. (64) Chief Bus. Officer